Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 453 results found. Search for [ sputnik v vaccine in india ]

Results 360 to 380 of 453
BusinessToday.In
October 30, 2020
Coronavirus vaccine update: Staff from eight of the 25 Moscow clinics where the trials are taking place said that the vaccination of new participants in the Phase 3 of trials have been temporarily paused


BusinessToday.In
New Delhi, October 29, 2020
Oxford and AstraZeneca's COVID-19 vaccine trials in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Sharing details of the final stage of the trial, Poonawalla said that his company had already given the first dose to more than 1,000 patients. He added that the vaccine is producing a good immune response in addition to antibodies and would be up to the UK and Indian health authorities to take a decision on how safe and effective it is. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's aims to wind up Phase-3 trials of Sputnik V by March 2021


PTI
October 29, 2020
On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia


BusinessToday.In
October 29, 2020
Dr Reddy's and Russian Direct Investment Fund (RDIF) joined hands to carry out clinical trials and distribute 100 million doses of Sputnik V vaccine across India


BusinessToday.In
October 29, 2020
Stocks to watch today on October 29: Wipro, Hero MotoCorp, GSK Pharma, SBI, L&T among others are the top stocks to watch out for in Thursday's trading session


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


Joe C Mathew
October 22, 2020
On October 22, domestic pharmaceutical major Dr Reddy's Laboratories informed the stock exchanges that the company had been the target of a cyber attack the previous night


Manoj Sharma
October 22, 2020
Dr Reddy's has partnered with Russian Direct Investment Fund to conduct trials of Sputnik V and distribute vaccine in India; after the cyber attack, its stock is 2.96% or Rs 149.20 down at Rs 4,897.55 compared to previous session's close of Rs 5,046.75


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 19, 2020
Chebrolu's invention is based on in-silico methodology. In this, a lead molecule selectively binds with spike protein of COVID-19. She is now planning to work with scientists who are working tirelessly to find vaccine against COVID-19


Rashi Bisaria
New Delhi, October 19, 2020
Reliance Jio plans to sells 5G smartphones at Rs 2,500-3,000Reliance Jio is planning to launch a 5G smartphone for less than Rs 5,000 and gradually reduce the price to Rs 2,500-3,000 a unit when it scales up the operation, according to a company official. The company will target 20-30 crore mobile phone users who use 2G connection at present.Coronavirus impact: Passenger vehicle exports dip 57.52% in Apr-SepPassenger vehicle exports bore the brunt of the pandemic in April-September period....


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


Joe C Mathew
October 18, 2020
Coronavirus vaccine: While there are no intranasal COVID-19 vaccines under trial in India at the moment, the two companies will pursue clinical trials of such vaccines in India in the coming months


BusinessToday.In
October 18, 2020
Coronavirus vaccine: Meanwhile, the Drug Control General of India (DCGI) on Saturday approved Dr Reddy's proposal to conduct clinical trials for Sputnik V in India


Rashi Bisaria
New Delhi, October 15, 2020
COVID-19 vaccine: Bharat Biotech fast-tracks Covaxin's trials, halves Phase 2 test sizeAs part of its effort to fast-track COVID-19 vaccine development, Hyderabad-based Bharat Biotech has cut the size of Phase 2 clinical trials of its indigenous coronavirus vaccine Covaxin by half. The vaccine, which Bharat Biotech is developing in collaboration with the country's apex medical research body - Indian Council of Medical Research (ICMR), will now be tested on 380 healthy volunteers in phase 2 a...


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


Associated Press
October 15, 2020
We now need to increase production of the first vaccine and the second vaccine, Russian President Vladimir Putin said, adding that the priority was to supply the Russian market with the vaccines


PB Jayakumar
October 14, 2020
The indicated price is for treatment using the drug for about a month, or a treatment cycle depending on the disease progression and patient condition


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


PAGES 19 OF 23  1617181920